Farnesol as a therapeutic mechanism, new evidence and future perspectives

Vol. 2, 2025 - 332620
Oral presentation
Favorite this paper
How to cite this paper?
Abstract

INTRODUCTION: In contemporary diseases, synthetic drugs play essential roles in both prevention and cure. Exogenous farnesol has been used to treat allergic asthma, diabetes, atherosclerosis, obesity, and hyperlipidemia. Farnesol has been found to promote wound healing by suppressing the production of pro-inflammatory cytokines such as interleukin (IL)-1 beta, IL-6, and tumor necrosis factor TNFα. OBJECTIVE: This study aims to review the current evidence on the mechanisms of action of farnesol and its clinical perspectives. METHODS: This study is an integrative literature review, carried out in the PubMed, SciELO, and Elsevier databases, considering articles published between 2015 and 2025. Of the 31 articles initially identified, 6 met the inclusion criteria. An in silico analysis was performed with the PubChem and PreADMET programs. RESULTS AND DISCUSSION: The analyzed studies showed that farnesol has the potential to reduce the formation of Candida albicans biofilms, act as a protective agent against skin lesions induced by pollutants, modulate inflammatory and apoptotic processes in different experimental models, in addition to exerting cardioprotective and neuroprotective effects. It has also demonstrated the ability to prevent induced cardiac hypertrophy and improve demyelinating characteristics in Charcot-Marie-Tooth disease type 1A. FINAL CONSIDERATIONS: The results suggest that farnesol has broad therapeutic applicability, and may contribute to the development of new treatments in areas such as oncology, cardiology, neurology, and inflammatory diseases

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Centro Universitário Maurício de Nassau - Redenção Sul
  • 2 Universidade Estadual do Piauí
  • 3 Centro Universitário Maurício de Nassau
  • 4 Universidade Estadual do Piauí - UESPI
Track
  • WG 35 - INNOVATION AND TECHNOLOGY IN HEALTH: DEVELOPMENT OF SOLUTIONS FOR THE HEALTH-DISEASE PROCESS
Keywords
Clinical Perspectives
Therapeutics
Biofilm
Inflammation